SEI Investments’s Alder Biopharmaceuticals ALDR Stock Holding History

SEI Investments’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$16K	–	3741
2018 Q2	$16K	Hold	1,000	–	–	﹤0.01%	2868
2018 Q1	$13K	Sell	1,000 -2,271	-69%	-$32.8K	﹤0.01%	2809
2017 Q4	$50K	Buy	3,271 +3,184	+3,660%	+$35.5K	﹤0.01%	2361
2017 Q3	$1K	Buy	+87	New	+$907	﹤0.01%	3155
2017 Q2	–	Sell	-25,584	Closed	-$532K	–	3386
2017 Q1	$532K	Buy	25,584 +24,517	+2,298%	+$543K	﹤0.01%	1566
2016 Q4	$22K	Buy	1,067 +3	+0.3%	+$78	﹤0.01%	2323
2016 Q3	$35K	Hold	1,064	–	–	﹤0.01%	2154
2016 Q2	$27K	Buy	+1,064	New	+$28.8K	﹤0.01%	2092
2015 Q4	–	Sell	-12,754	Closed	-$418K	–	2783
2015 Q3	$418K	Buy	12,754 +10,832	+564%	+$461K	﹤0.01%	1354
2015 Q2	$102K	Buy	+1,922	New	+$69.9K	﹤0.01%	1539

Other funds holding ALDR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SEI Investments's ALDR Position: Q3 2018 in Review

SEI Investments sold out of Alder Biopharmaceuticals (ALDR) in Q3 2018, closing a stake of 1,000 shares — an estimated $16K sold.

SEI Investments first reported a position in ALDR in Q2 2015 and held it in 10 quarters. The position peaked at $532K in Q1 2017. 127 funds tracked by Wall St. Rank hold ALDR as of Q3 2018.

SEI Investments reported no remaining Alder Biopharmaceuticals position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 1,000 Alder Biopharmaceuticals shares in Q3 2018, an estimated $16K.
SEI Investments first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 10 quarters.
SEI Investments's Alder Biopharmaceuticals position peaked at $532K in Q1 2017.
127 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.